{
  "success": true,
  "sourceFile": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\input\\trial\\NCT02576509_CheckMate227\\NCT02576509_CheckMate227_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-3-flash-preview",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "All Randomized Subjects",
        "text": "The study's primary endpoint is OS in all randomized subjects. This population includes all subjects who were randomized to a treatment arm through the IVRS, regardless of whether they received study medication.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "ITT",
        "populationDescription": "The study's primary endpoint is OS in all randomized subjects. This population includes all subjects who were randomized to a treatment arm through the IVRS, regardless of whether they received study medication.",
        "criteria": "Randomized through IVRS"
      },
      {
        "id": "pop_2",
        "name": "Safety Analysis Set",
        "text": "The safety analysis will be performed on all subjects who received at least one dose of study drug (nivolumab or sorafenib).",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "populationDescription": "The safety analysis will be performed on all subjects who received at least one dose of study drug (nivolumab or sorafenib).",
        "criteria": "Received >= 1 dose of study drug"
      },
      {
        "id": "pop_3",
        "name": "Enrolled Subjects",
        "text": "Every subject that signs the informed consent form must be assigned a subject number in IVRS and is considered an enrolled subject.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "Enrolled",
        "populationDescription": "Every subject that signs the informed consent form must be assigned a subject number in IVRS and is considered an enrolled subject.",
        "criteria": "Signed informed consent AND assigned subject number in IVRS"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Etiology",
        "code": "ETIOLOGY",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Etiology",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "HCV vs. non-HCV (ie, HBV and HCC with no history of hepatitis virus infection)"
      },
      {
        "id": "char_2",
        "name": "Vascular invasion and/or extrahepatic spread",
        "code": "VASCULAR_INVASION_AN",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Vascular invasion and/or extrahepatic spread",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Presence or absence of vascular invasion and/or extrahepatic spread"
      },
      {
        "id": "char_3",
        "name": "Geography",
        "code": "GEOGRAPHY",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Geography",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Asia vs Non-Asia"
      },
      {
        "id": "char_4",
        "name": "Age",
        "code": "AGE",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age of the subject in years"
      },
      {
        "id": "char_5",
        "name": "PD-L1 Expression",
        "code": "PD-L1_EXPRESSION",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "PD-L1 Expression",
        "dataType": "Categorical/Numeric",
        "instanceType": "Characteristic",
        "description": "Tumor PD-L1 expression levels"
      }
    ],
    "summary": {
      "populationCount": 3,
      "characteristicCount": 5
    }
  }
}